drugset / Trial / NCT01152996
Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension Study
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the long-term safety and tolerability of vortioxetine, once daily (QD), in participants with major depressive disorder.
Timeline
- Start
- 2010-09
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vortioxetine | Unknown | 15 mg | Oral |
| Subject | Vortioxetine | Unknown | 20 mg | Oral |